Shandong Wit Dyne HealthLtd (SZSE:000915) Sheds CN¥452m, Company Earnings and Investor Returns Have Been Trending Downwards for Past Year
Shandong Wit Dyne HealthLtd (SZSE:000915) Sheds CN¥452m, Company Earnings and Investor Returns Have Been Trending Downwards for Past Year
Passive investing in an index fund is a good way to ensure your own returns roughly match the overall market. Active investors aim to buy stocks that vastly outperform the market - but in the process, they risk under-performance. Investors in Shandong Wit Dyne Health Co.,Ltd. (SZSE:000915) have tasted that bitter downside in the last year, as the share price dropped 20%. That's well below the market return of 14%. At least the damage isn't so bad if you look at the last three years, since the stock is down 9.5% in that time. On top of that, the share price is down 7.1% in the last week.
被動投資於指數基金是一種確保您自己的回報大致與整體市場相符的好方法。主動投資者的目標是購買遠遠超過市場表現的股票——但在這個過程中,他們面臨着表現不佳的風險。山東華特達因健康股份有限公司(SZSE:000915)的投資者在過去一年嚐到了這種苦澀的下行,因爲股價下跌了20%。這遠低於市場回報的14%。如果查看過去三年,損失至少沒有那麼嚴重,因爲在這段時間內,股票下跌了9.5%。此外,過去一週股價下跌了7.1%。
After losing 7.1% this past week, it's worth investigating the company's fundamentals to see what we can infer from past performance.
在過去一週下跌了7.1%之後,值得調查公司的基本面,以了解我們可以從過去的表現中推斷出什麼。
While the efficient markets hypothesis continues to be taught by some, it has been proven that markets are over-reactive dynamic systems, and investors are not always rational. By comparing earnings per share (EPS) and share price changes over time, we can get a feel for how investor attitudes to a company have morphed over time.
儘管有效市場假說仍然被一些人教授,但已經證明市場是一種反應過度的動態系統,投資者並不總是理性。通過比較每股收益(EPS)和股價變化,我們可以感受到投資者對公司的態度在一段時間內是如何變化的。
Unfortunately Shandong Wit Dyne HealthLtd reported an EPS drop of 7.1% for the last year. The share price decline of 20% is actually more than the EPS drop. So it seems the market was too confident about the business, a year ago.
不幸的是,山東華特達因健康有限公司報告了去年每股收益下降7.1%。股價下跌20%實際上超過了每股收益的下降。因此,似乎市場在一年前對這項業務過於自信。
The graphic below depicts how EPS has changed over time (unveil the exact values by clicking on the image).
下圖顯示了EPS隨時間變化的情況(點擊圖像以顯示確切值)。
Before buying or selling a stock, we always recommend a close examination of historic growth trends, available here.
在買入或賣出股票之前,我們總是建議仔細審查歷史增長趨勢,詳情請見這裏。
What About Dividends?
關於分紅派息的問題
As well as measuring the share price return, investors should also consider the total shareholder return (TSR). The TSR incorporates the value of any spin-offs or discounted capital raisings, along with any dividends, based on the assumption that the dividends are reinvested. Arguably, the TSR gives a more comprehensive picture of the return generated by a stock. In the case of Shandong Wit Dyne HealthLtd, it has a TSR of -14% for the last 1 year. That exceeds its share price return that we previously mentioned. And there's no prize for guessing that the dividend payments largely explain the divergence!
除了測量股價回報,投資者還應考慮總股東回報(TSR)。TSR包括任何分拆或折價融資的價值,以及任何分紅派息,假設這些分紅派息被再投資。可以說,TSR提供了一個更全面的股票回報圖景。以華特達因爲例,在過去一年中,其TSR爲-14%。這超過了我們之前提到的股價回報。而且,分紅派息大幅解釋了這種差異,這是不言而喻的!
A Different Perspective
不同的視角
While the broader market gained around 14% in the last year, Shandong Wit Dyne HealthLtd shareholders lost 14% (even including dividends). However, keep in mind that even the best stocks will sometimes underperform the market over a twelve month period. On the bright side, long term shareholders have made money, with a gain of 1.5% per year over half a decade. If the fundamental data continues to indicate long term sustainable growth, the current sell-off could be an opportunity worth considering. It's always interesting to track share price performance over the longer term. But to understand Shandong Wit Dyne HealthLtd better, we need to consider many other factors. For example, we've discovered 1 warning sign for Shandong Wit Dyne HealthLtd that you should be aware of before investing here.
儘管大盤在過去一年上漲了約14%,但是華特達因的股東卻損失了14%(即使包括分紅派息)。但是,請記住,即使是最好的股票,有時在12個月的時間裏也會表現不及大盤。從積極的一面來看,長期股東一直在盈利,過去五年每年獲得1.5%的收益。如果基本數據繼續顯示長期可持續增長,目前的拋售可能是一個值得考慮的機會。跟蹤長期的股價表現總是很有趣。然而,要更好地了解華特達因,我們還需要考慮許多其他因素。例如,我們發現華特達因有1個你在此投資前應該注意的警告信號。
If you are like me, then you will not want to miss this free list of undervalued small caps that insiders are buying.
如果你像我一樣,那麼你一定不想錯過這份內部人士正在購買的被低估的小型股免費名單。
Please note, the market returns quoted in this article reflect the market weighted average returns of stocks that currently trade on Chinese exchanges.
請注意,本文中引用的市場回報反映了目前在中國交易所交易的股票的市場加權平均回報。
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
對本文有反饋?對內容有疑慮?請直接與我們聯繫。或者,發送電子郵件至 editorial-team (at) simplywallst.com。
這篇來自Simply Wall ST的文章是一般性的。我們根據歷史數據和分析師預測提供評論,採用無偏見的方法,我們的文章並不旨在提供財務建議。它不構成對任何股票的買入或賣出建議,也未考慮到您的目標或財務狀況。我們旨在爲您提供以基本數據驅動的長期分析。請注意,我們的分析可能未考慮最新的價格敏感公司公告或定性材料。Simply Wall ST在提到的任何股票中均沒有持倉。